PT - JOURNAL ARTICLE AU - Granell, R AU - Curtin, JA AU - Haider, S AU - Kitaba, N AU - Mathie, S AU - Gregory, L AU - Yates, LL AU - Tutino, M AU - Hankinson, J AU - Perretti, M AU - Vonk, JM AU - Arshad, SH AU - Cullinan, P AU - Fontanella, S AU - Roberts, G AU - Koppelman, GH AU - Simpson, A AU - Turner, S AU - Murray, CS AU - Lloyd, CM AU - Holloway, JW AU - Custovic, A AU - UNICORN Investigators AU - Breathing Together Investigators TI - A meta-analysis of genome-wide association studies of childhood wheezing phenotypes identifies <em>ANXA1</em> as a susceptibility locus for persistent wheezing AID - 10.1101/2023.03.03.23284449 DP - 2023 Jan 01 TA - medRxiv PG - 2023.03.03.23284449 4099 - http://medrxiv.org/content/early/2023/03/05/2023.03.03.23284449.short 4100 - http://medrxiv.org/content/early/2023/03/05/2023.03.03.23284449.full AB - Background Many genes associated with asthma explain only a fraction of its heritability. Most genome-wide association studies (GWASs) used a broad definition of “doctor-diagnosed asthma”, thereby diluting genetic signals by not considering asthma heterogeneity. The objective of our study was to identify genetic associates of childhood wheezing phenotypes.Methods We conducted a novel multivariate GWAS meta-analysis of wheezing phenotypes jointly derived using unbiased analysis of data collected from birth to 18 years in 9,568 individuals from five UK birth-cohorts.Results 44 independent SNPs were associated with early-onset persistent, 25 with preschool remitting, 33 with mid-childhood remitting and 32 with late onset wheeze. We identified a novel locus on chr9q21.13 (close to annexin 1 (ANXA1), p&lt;6.7×10−9), associated exclusively with early-onset persistent wheeze. We identified rs75260654 as the most likely causative single nucleotide polymorphism (SNP) using Promoter Capture Hi-C loops, and then showed that the risk allele (T) confers a reduction in ANXA1 expression. Finally, in a murine model of house dust mite (HDM)-induced allergic airway disease, we demonstrated that anxa1 protein expression increased and anxa1 mRNA was significantly induced in lung tissue following HDM exposure. Using anxa1−/− deficient mice, we showed that loss of anxa1 results in heightened airway hyperreactivity and Th2 inflammation upon allergen challenge.Conclusions We discovered a novel locus uniquely associated with early-onset persistent wheeze, identified the most likely causative variant, and showed that ANXA1 may play a role in regulating the pulmonary immune response to allergens. Targeting this pathway in persistent disease may represent an exciting therapeutic prospect.Competing Interest StatementGraham Roberts: MRC grant to my institution President of the British Society of Allergy and Clinical Immunology. Gerard Koppelman: Dutch Lung Foundation, Ubbo Emmius Foundation (Money to insititution) Dutch Lung Foundation, Vertex, TEVA the Netherlands, GSK, ZON-MW (VICI grant), European Union (Money to institution) Astra Zeneca, Pure IMS, GSK (Money to institution) Sanofi, Boehringer Ingelheim (Money to institution). Angela Simpson: Medical research council Research grant JP Moulton Charitable Foundation Research grant Asthma UK Research grant. Clare Murray: Asthma Uk National Institute for Health Research Moulton Charitable Foundation North West Lung Centre Charity GSK (Lecture fees) Novartis (Lecture fees). Clare Lloyd: Wellcome Trust 107059/Z/15/Z. John Holloway: Medial Research Council grant MR/S025340/1 (to institution) American Academy of Allergy Asthma and Immunology (AAAI) (Support for speaker travel to AAAAI annual congress). Adnan Custovic: MRC (research grants) EPSRC (research grant) Wellcome Trust (research grant) Worg Pharmaceoticals (Personal payment &lt;US$5000) GSK Honorarium for lecture, personal, &lt;US$ 5000 AstraZeneca Honorarium for lecture, personal, &lt;US$ 5000 Sanofi Honorarium for lecture, personal, &lt;US$ 5000 Stallergens-Greer Honorarium for lecture, personal, &lt;US$ 5000 WAO (Board of officers, unpaid).Funding StatementSupported by the UK Medical Research Council (MRC) Programme Grant MR/S025340/1, the Wellcome Trust (WT) Strategic Award (108,818/15/Z) and a WT Senior Fellowship to CML (107059/Z/15/Z). The MRC and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. ALSPAC GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). PIAMA was funded by the Netherlands Lung Foundation (grant 3.4.01.26, 3.2.06.022, 3.4.09.081 and 3.2.10.085CO), the ZON-MW Netherlands Organization for Health Research and Development (grant 912-03-031), the Stichting Astmabestrijding and the Ministry of the Environment. Genome-wide genotyping was funded by the European Commission as part of GABRIEL (grant number 018996) and a grant from BBMRI-NL (CP 29). GHK is supported by a ZON-MW VICI grant. This research was funded in part by the Wellcome Trust [217065/Z/19/Z]. For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Study Team for Early Life Asthma Research (STELAR) consortium brings together five UK population−based birth cohorts: Avon Longitudinal Study of Parents and Children (ALSPAC), Ashford and Isle of Wight (IOW), Manchester Asthma and Allergy Study (MAAS) and the Aberdeen Study of Eczema and Asthma to Observe the Effects of Nutrition (SEATON). Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time. MAAS was approved by the North West Greater Manchester East Research Ethics Committee. SEATON was approved by the North of Scotland Research Ethics Committee. Ethics approvals were obtained from the Isle of Wight Local Research Ethics Committee (now named the National Research Ethics Service, NRES Committee South Central Southampton B) at recruitment and for the subsequent follow-ups. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe informed consent obtained from all included participants does not allow the data to be made freely available through any third party maintained public repository. However, data used for this submission can be made available on request to the corresponding cohort Executive. The ALSPAC website provides information on how to request and access its data (http://www.bristol.ac.uk/alspac/researchers/access/). For queries regarding access of data from MAAS, IoW, SEATON or Ashford please contact Philip Couch philip.couch@manchester.ac.uk). All summary data used to plot the figures in our manuscript has been deposited in Dryad. https://datadryad.org/stash/share/NtN5Q2cplp016xWs3QAbYkR8LamBxRVIGOQ6JmzWopQ